31645112,"Prevalence and characteristics of headache attributed to ingestion or inhalation of a cold stimulus (HICS): A cross-sectional study","Kraya T, Schulz-Ehlbeck M, Burow P, Watzke S, Zierz S.","Cephalalgia. 2020 Mar
31316454,"Increased Blood Flow Velocity in Middle Cerebral Artery and Headache Upon Ingestion of Ice Water","Hensel O, Burow P, Mages S, Wienke A, Kraya T, Zierz S.","Front Neurol. 2019 Jun 28
30729751,"Functional characterization of a novel CSF1R mutation causing hereditary diffuse leukoencephalopathy with spheroids","Kraya T, Quandt D, Pfirrmann T, Kindermann A, Lampe L, Schroeter ML, Kohlhase J, Stoevesandt D, Hoffmann K, Villavicencio-Lorini P.","Mol Genet Genomic Med. 2019 Apr
30847888,"[Headache - an Update 2018]","Diener HC, Gaul C, Holle-Lee D, Jürgens TP, Kraya T, Kurth T, Nägel S, Neeb L, Straube A.","Laryngorhinootologie. 2019 Mar 30671821,"[Headache and stroke]","Keidel M, Kraya T.","MMW Fortschr Med. 2019 Jan
29289801,"Cognitive impairment, clinical severity and MRI changes in MELAS syndrome","Kraya T, Neumann L, Paelecke-Habermann Y, Deschauer M, Stoevesandt D, Zierz S, Watzke S.","Mitochondrion. 2019 Jan
Mensch A, Zierz S, Kraya T. Distale Myopathien: Klassifikation, Phänotypen, Genotypen und diagnostisches Vorgehen. 2019. Nervenheilkunde 2019.38(06):381-388.
Dresler Th, Klan T, Liesering-Latta E, Lüpke J, Hubalek I, Kraya T, Kropp P. Psychologische Behandlungsverfahren bei Kopfschmerz. Nervenheilkunde 2019; 38(10): 745-758.
Obermann M, Nägel S, Ose C, Sonuc N, Scherag A, Storch P, Gaul C, Böger A, Kraya T, Jansen JP, Straube A, Freilinger T, Kaube H, Jürgens TP, Diener HC, Katsarava Z, Kleinschnitz C, Holle D. Obermann M, et al. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial. Lancet Neurol. 2020 Nov 24:S1474-4422(20)30363-X. doi: 10.1016/S1474-4422(20)30363-X. Online ahead of print. Lancet Neurol. 2020. PMID: 33245858
Kraya T, Schulz-Ehlbeck M, Burow P, Watzke S, Zierz S. Prevalence and characteristics of headache attributed to ingestion or inhalation of a cold stimulus (HICS): A cross-sectional study. Cephalalgia. 2020 Mar;40(3):299-306
Mensch A*, Kraya T*, Koester F, Müller T, Stoevesandt D, Zierz S. Whole-body muscle MRI of patients with MATR3-associated distal myopathy reveals a distinct pattern of muscular involvement and highlights the value of whole-body examination. J Neurol. 2020 Aug;267(8):2408-2420.
Lehmann Urban D, Lehmann E, Motlagh Scholle L, Kraya T. Myalgia in 30 Patients with Suspected Myopathy. Int J Environ Res Public Health. 2020 Apr 6;17(7):2502.
Diener HC, Förderreuther S, Gaul C, Giese F, Hamann T, Holle-Lee D, Jürgens TP, Kamm K, Kraya T, Lampl C, May A, Reuter U, Scheffler A, Tfelt-Hansen P. Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor: Addition to the S1 guideline: Therapy of migraine attacks and prevention of migraine. Recommendations of the Germany Society of Neurology and the German Migraine and Headache Society. Neurol Res Pract. 2020 Apr 13;2:11
Hämmerl L, Kraya T. Medikamenteninduzierter Kopfschmerz. In Stufen zu mehr schmerz-freien Tagen. Der Allgemeinarzt 14/2020.
Ehler T, Kraya T. Migräne im Kindes- und Jugendalter. pädiatrische praxis. 2020. 94:538-547.
Hämmerl L. Kraya T. Neue Migränetherapien. Ärzteblatt Sachsen. 2020. 09:18-23.
34406609,"Pooled retrospective analysis of 70 mg erenumab in episodic and chronic migraine: a two tertiary headache centers experience during clinical practice","Storch P, Burow P, Möller B, Kraya T, Heintz S, Politz N, Naegel S.","Acta Neurol Belg. 2022 Aug
33683636,"Headache and migraine in mitochondrial disease and its impact on life-results from a cross-sectional, questionnaire-based study","Burow P, Meyer A, Naegel S, Watzke S, Zierz S, Kraya T.","Acta Neurol Belg. 2021 Oct
34572118,"The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine","Burow P, Haselier M, Naegel S, Scholle LM, Gaul C, Kraya T.","Cells. 2021 Sep 18
34046722,"[Telemedicine in stroke-pertinent to stroke care in Germany]","Barlinn J, Winzer S, Worthmann H, Urbanek C, Häusler KG, Günther A, Erdur H, Görtler M, Busetto L, Wojciechowski C, Schmitt J, Shah Y, Büchele B, Sokolowski P, Kraya T, Merkelbach S, Rosengarten B, Stangenberg-Gliss K, Weber J, Schlachetzki F, Abu-Mugheisib M, Petersen M, Schwartz A, Palm F, Jowaed A, Volbers B, Zickler P, Remi J, Bardutzky J, Bösel J, Audebert HJ, Hubert GJ, Gumbinger C.","Nervenarzt. 2021 Jun
33779998,"Erenumab for migraine prevention in a patient with mitochondrial encephalopathy, lactate acidosis, and stroke-like episodes syndrome: A case report","Naegel S, Burow P, Holle D, Stoevesandt D, Heintz S, Thaele A, Zierz S, Kraya T.","Headache. 2021 Apr
33459760,"Bi-allelic truncating mutations in VWA1 cause neuromyopathy","Deschauer M, Hengel H, Rupprich K, Kreiß M, Schlotter-Weigel B, Grimmel M, Admard J, Schneider I, Alhaddad B, Gazou A, Sturm M, Vorgerd M, Balousha G, Balousha O, Falna M, Kirschke JS, Kornblum C, Jordan B, Kraya T, Strom TM, Weis J, Schöls L, Schara U, Zierz S, Riess O, Meitinger T, Haack TB.","Brain. 2021 Mar 3
33245858,"Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial","Obermann M, Nägel S, Ose C, Sonuc N, Scherag A, Storch P, Gaul C, Böger A, Kraya T, Jansen JP, Straube A, Freilinger T, Kaube H, Jürgens TP, Diener HC, Katsarava Z, Kleinschnitz C, Holle D.","Lancet Neurol. 2021 Jan
Nägel S, Kraya T. Trigeminoautonome Kopfschmerzen. Neurologie up2date. 2021. 04(03):255-268.
Hämmerl L, Kraya T. Update 2021: Therapieempfehlungen Akuttherapie der Migräne. Phamakon. 09(03), 2021: 200-206(7).
36287263,[Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis],Goßrau G, Förderreuther S, Ruscheweyh R, Ruschil V, Sprenger T, Lewis D, Kamm K, Freilinger T, Neeb L, Malzacher V, Meier U, Gehring K, Kraya T, Dresler T, Schankin CJ, Gantenbein AR, Brössner G, Zebenholzer K, Diener HC, Gaul C, Jürgens TP.,Schmerz. 2022 Oct 26:1-11. doi: 10.1007/s00482-022-00671-9. Online ahead of print.,Goßrau G,Schmerz,2022,2022/10/26,PMC9607711,10.1007/s00482-022-00671-9
36287216,[Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis],Goßrau G, Förderreuther S, Ruscheweyh R, Ruschil V, Sprenger T, Lewis D, Kamm K, Freilinger T, Neeb L, Malzacher V, Meier U, Gehring K, Kraya T, Dresler T, Schankin CJ, Gantenbein AR, Brössner G, Zebenholzer K, Diener HC, Gaul C, Jürgens TP.,Nervenarzt. 2022 Oct 26:1-11. doi: 10.1007/s00115-022-01403-1. Online ahead of print.,Goßrau G,Nervenarzt,2022,2022/10/26,PMC9607745,10.1007/s00115-022-01403-1
34406609,Pooled retrospective analysis of 70 mg erenumab in episodic and chronic migraine: a two tertiary headache centers experience during clinical practice,Storch P, Burow P, Möller B, Kraya T, Heintz S, Politz N, Naegel S.,Acta Neurol Belg. 2022 Aug 122(4):931-937. doi: 10.1007/s13760-021-01770-7. Epub 2021 Aug 18.,Storch P,Acta Neurol Belg, 2022,2021/08/18, PMC9300569, 10.1007/s13760-021-01770-7
35906498,Vertebrobasilar artery elongation in migraine-a retrospective cross-sectional study,Hensel O, Burow P, Kraya T, Stoevesandt D, Naegel S.,Acta Neurol Belg. 2022 Jul 29. doi: 10.1007/s13760-022-02039-3. Online ahead of print.,Hensel O,Acta Neurol Belg,2022,2022/07/29,10.1007/s13760-022-02039-3
35840895,Correction: The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients,Ruscheweyh R, Klonowski T, Goßrau G, Kraya T, Gaul C, Straube A, Jürgens TP, Scheidt J, Förderreuther S., J Headache Pain. 2022 Jul 15 23(1):82. doi: 10.1186/s10194-022-01453-5., Ruscheweyh R, J Headache Pain,2022", 2022/07/15 PMC9288007, 10.1186/s10194-022-01453-5
35773650, The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients, Ruscheweyh R, Klonowski T, Goßrau G, Kraya T, Gaul C, Straube A, Jürgens TP, Scheidt J, Förderreuther S., J Headache Pain. 2022 Jul 1 23(1):74. doi: 10.1186/s10194-022-01447-3., Ruscheweyh R, J Headache Pain, 2022, 2022/06/30, PMC9248100, 10.1186/s10194-022-01447-3
35513671 [The Headache Registry of the German Migraine und Headache Society], Ruscheweyh R, Dresler T, Goßrau G, Kraya T, Gaul C, Förderreuther S., MMW Fortschr Med. 2022 May 164(9):53-57. doi: 10.1007/s15006-022-0971-3., Ruscheweyh R, MMW Fortschr Med, 2022, 2022/05/05, 10.1007/s15006-022-0971-3
35294984, [Trigeminal Autonomic Cephalgias], Nägel S, Kraya T., Fortschr Neurol Psychiatr. 2022 Mar 90(3):121-134. doi: 10.1055/a-1706-5952. Epub 2022 Mar 16., Nägel S, Fortschr Neurol Psychiatr, 2022, 2022/03/16, 10.1055/a-1706-5952
Ruscheweyh R, Klonowski T, Goßrau G, Kraya T, Gaul C, Straube A, Jürgens TP, Scheidt J, Förderreuther S. The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients. J Headache Pain. 2022 Jul 1;23(1):74
Storch P, Burow P, Möller B, Kraya T, Heintz S, Politz N, Naegel S. Pooled retrospective analysis of 70 mg erenumab in episodic and chronic migraine: a two tertiary headache centers experience during clinical practice. Acta Neurol Belg. 2022 Aug;122(4):931-937
Mensch A, Nägel S, Zierz S, Kraya T, Stoevesandt D. Bildgebung der Muskulatur bei Neuromuskulären Erkrankungen – von der Initialdiagnostik bis zur Verlaufsbeurteilung. Klinische Neurophysiologie 2022; 53(01): 36-47.
Kraya T, Mensch A, Zierz S, Nägel S. Update Distale Myopathien. Klinische Neurophysiologie 202253(01):23-28.
Goßrau G, Förderreuther S, Ruscheweyh R, Ruschil V, Sprenger T, Lewis D, Kamm K, Freilinger T, Neeb L, Malzacher V, Meier U, Gehring K, Kraya T, Dresler T, Schankin CJ, Gantenbein AR, Brössner G, Zebenholzer K, Diener HC, Gaul C, Jürgens TP. Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen Migräneprophylaxe [Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. Schmerz. 2023 Feb;37(1):5-16.
Goßrau G, Förderreuther S, Ruscheweyh R, Ruschil V, Sprenger T, Lewis D, Kamm K, Freilinger T, Neeb L, Malzacher V, Meier U, Gehring K, Kraya T, Dresler T, Schankin CJ, Gantenbein AR, Brössner G, Zebenholzer K, Diener HC, Gaul C, Jürgens TP. Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen Migräneprophylaxe [Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. Nervenarzt. 2023 Apr;94(4):306-317.
Hensel O, Burow P, Kraya T, Stoevesandt D, Naegel S. Vertebrobasilar artery elongation in migraine-a retrospective cross-sectional study. Acta Neurol Belg. 2023 Apr;123(2):441-450
Straube A, Broessner G, Gaul C, Hamann X, Hipp J, Kraya T, Neeb L. Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: a subgroup analysis of the Finesse Study. J Headache Pain. 2023 May 23;24(1):59.
Ruscheweyh R, Gossrau G, Dresler T, Freilinger T, Förderreuther S, Gaul C, Kraya T, Neeb L, Ruschil V, Straube A, Scheidt J, Jürgens TP. Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry. J Headache Pain. 2023 Oct 10;24(1):135
Hämmerl L, Kraya T. Migräne und mitochondriale Erkrankungen : Energiedefizit im Gehirn [Migraine and mitochondrial diseases : Energy deficit in the brain]. Schmerz. 2023 Nov 3. German.